Fortfahren mit
SML3983
BAY 2686013
≥98% (HPLC)
Synonym(e):
2-amino-N-(4-((3,5-bis(trifluoromethyl)benzyl)oxy)phenyl)acetamide hydrochloride
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|
Über diesen Artikel
Quality Segment
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C(CN)NC(C=C1)=CC=C1OCC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2.Cl
InChI
1S/C17H14F6N2O2.ClH/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)9-27-14-3-1-13(2-4-14)25-15(26)8-24;/h1-7H,8-9,24H2,(H,25,26);1H
InChI key
LDIQEQUVXGCYRE-UHFFFAOYSA-N
Biochem/physiol Actions
BAY 2686013 is an orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
Disclaimer
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description ≥98% (HPLC) | description - | description Increases cAMP levels in a dose-dependent manner (EC50 = 4.7 nM). | description More active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50 = 7 nM). |
| assay ≥98% (HPLC) | assay - | assay ≥97% (HPLC) | assay ≥96% (HPLC) |
| form powder | form powder | form solid | form solid |
| Quality Level 100 | Quality Level 200 | Quality Level 100 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| storage condition desiccated | storage condition - | storage condition desiccated (hygroscopic), OK to freeze | storage condition desiccated (hygroscopic), OK to freeze |
| solubility DMSO: 2 mg/mL, clear | solubility - | solubility 5% acetic acid: 1 mg/mL | solubility 5% acetic acid: 1 mg/mL |
Lagerklasse
11 - Combustible Solids
WGK
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.